ALC:NYSE
Alcon AG
$70.17
arrow_downward
-0.69%(-0.49) 1D
$70.17
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 23, 4:00:05 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$70.16
High
$70.46
Low
$69.54
Mkt. cap
28.81B
Avg. vol.
1.77M
Volume
2.59M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.88
Shares outstanding
483.40M
No. of employees
25K
Open
$70.16
High
$70.46
Low
$69.54
Mkt. cap
28.81B
Avg. vol.
1.77M
Volume
2.59M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.88
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
아시아경제
·
27 minutes ago
U.S. S&P 500 Q3 Net Income Seen Rising 30%... Nvidia and Micron to Drive 34% of Increase
Traders Union
·
1 hour ago
S&P 500 has averaged 1.9 percent gain in November since 1950, Phil Rosen notes
24/7 Wall St.
·
32 minutes ago
3 Dividend ETFs With Over $10 Billion Each Pay Up to 3.31% and Beat the S&P 500 Over the Past Year
The Motley Fool
·
4 hours ago
Up 35%, How Long Can Coca-Cola Continue Crushing the S&P 500?
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorMedical device
Websitealcon.com